[HTML][HTML] Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

NA Muena, T García-Salum, C Pardo-Roa… - …, 2022 - thelancet.com
Background A major challenge of the SARS-CoV-2 pandemic is to better define" protective
thresholds" to guide the global response. We aimed to characterize the longitudinal …

[HTML][HTML] Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

NA Muena, T García-Salum, C Pardo-Roa… - eBioMedicine, 2022 - Elsevier
Background A major challenge of the SARS-CoV-2 pandemic is to better define “protective
thresholds” to guide the global response. We aimed to characterize the longitudinal …

[HTML][HTML] Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

NA Muena, T García-Salum, C Pardo-Roa… - …, 2022 - ncbi.nlm.nih.gov
Background A major challenge of the SARS-CoV-2 pandemic is to better define “protective
thresholds” to guide the global response. We aimed to characterize the longitudinal …

[PDF][PDF] Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

NA Muena, T García-Salum, C Pardo-Roa… - 2022 - scienceopen.com
Background A major challenge of the SARS-CoV-2 pandemic is to better define “protective
thresholds” to guide the global response. We aimed to characterize the longitudinal …

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

NA Muena, T García-Salum, C Pardo-Roa… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background A major challenge of the SARS-CoV-2 pandemic is to better define" protective
thresholds" to guide the global response. We aimed to characterize the longitudinal …

[PDF][PDF] Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

NA Muena, T García-Salum, C Pardo-Roa… - 2022 - academia.edu
Background A major challenge of the SARS-CoV-2 pandemic is to better define “protective
thresholds” to guide the global response. We aimed to characterize the longitudinal …

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

NA Muena, T García-Salum, C Pardo-Roa… - …, 2022 - einstein.elsevierpure.com
Background: A major challenge of the SARS-CoV-2 pandemic is to better define “protective
thresholds” to guide the global response. We aimed to characterize the longitudinal …

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals.

NA Muena, T García-Salum, C Pardo-Roa… - Ebiomedicine, 2022 - europepmc.org
Background A major challenge of the SARS-CoV-2 pandemic is to better define" protective
thresholds" to guide the global response. We aimed to characterize the longitudinal …

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals.

NA Muena, T García-Salum, C Pardo-Roa… - Ebiomedicine, 2022 - europepmc.org
Background A major challenge of the SARS-CoV-2 pandemic is to better define" protective
thresholds" to guide the global response. We aimed to characterize the longitudinal …